SAMSUNG PHARM. Co., LTD. (KRX:001360)

SAMSUNG PHARM. Co., LTD. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2018	FY 2017	FY 2016
Period Ending	May 14, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Market Capitalization	166,593	144,757	145,987	147,229	166,368	166,026
Market Cap Growth	17.69%	-0.84%	-0.84%	-11.50%	0.21%	-34.48%
Enterprise Value	-	-	-	124,596	212,663	177,122
Last Close Price	1770.00	1538.00	1962.35	2282.64	3317.58	3453.75
PE Ratio	13.11	11.39	5.88	-	-	-
PS Ratio	3.76	3.27	2.81	3.17	3.97	3.52
PB Ratio	-	-	-	1.12	1.77	2.02
P/TBV Ratio	-	-	-	1.12	1.78	2.08
P/OCF Ratio	-	-	-	-	32.29	-
EV/Sales Ratio	-	-	-	2.68	5.07	3.75
Debt / Equity Ratio	-	-	-	0.14	0.48	0.54
Net Debt / Equity Ratio	-	-	-	-0.11	0.20	0.39
Net Debt / EBITDA Ratio	-	-	-	9.15	-4.85	-15.42
Net Debt / FCF Ratio	-	-	-	1.64	-19.57	-0.74
Asset Turnover	-	-	-	0.30	0.29	0.35
Inventory Turnover	-	-	-	3.81	3.10	3.37
Quick Ratio	-	-	-	2.18	0.87	0.78
Current Ratio	-	-	-	3.10	1.17	1.31
Return on Equity (ROE)	-	-	-	-1.84%	-8.25%	-26.77%
Return on Assets (ROA)	-	-	-	-2.14%	-3.32%	-2.94%
Return on Capital Employed (ROCE)	-	-	-	-4.00%	-7.60%	-6.20%
Earnings Yield	7.63%	8.78%	17.00%	-1.41%	-4.53%	-13.02%
FCF Yield	-	-	-	-6.20%	-0.57%	-26.01%
Buyback Yield / Dilution	-	-	-	-28.44%	-21.80%	-28.46%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.